338 related articles for article (PubMed ID: 33839699)
41. lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p.
Dong LI; Zheng Y; Gao L; Luo X
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):870-882. PubMed ID: 33984130
[TBL] [Abstract][Full Text] [Related]
42. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
43. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
[TBL] [Abstract][Full Text] [Related]
44. EriB targeted inhibition of microglia activity attenuates MPP
Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of HTRA1 mediated by the lncRNA NEAT1/miR-141-3p axis contributes to endometriosis development through activating NLRP3 inflammasome-mediated pyroptotic cell death and cellular inflammation.
Li L; Ye K; Wang D
In Vitro Cell Dev Biol Anim; 2023 Mar; 59(3):166-178. PubMed ID: 37017808
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
Tan J; Fan J; He J; Zhao L; Tang H
J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
[TBL] [Abstract][Full Text] [Related]
48. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
49. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
[TBL] [Abstract][Full Text] [Related]
50. Baicalin attenuates lipopolysaccharide-induced renal tubular epithelial cell injury by inhibiting the TXNIP/NLRP3 signalling pathway via increasing miR-223-3p expression.
Sun Y; Liu MW; Zhao YH; Lu YX; Wang YA; Tong CW
J Biol Regul Homeost Agents; 2020; 34(1):69-82. PubMed ID: 32392921
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of microRNA-143-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting FSTL1.
Wang S; Liu Z
Neuromolecular Med; 2021 Dec; 23(4):500-510. PubMed ID: 33709299
[TBL] [Abstract][Full Text] [Related]
52. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
[TBL] [Abstract][Full Text] [Related]
53. MALAT1 Mediates
Geng X; Zou Y; Li S; Qi R; Yu H; Li J
Mediators Inflamm; 2023; 2023():4477492. PubMed ID: 37064502
[TBL] [Abstract][Full Text] [Related]
54. LINC00943 acts as miR-338-3p sponge to promote MPP
Sun X; Zhang C; Tao H; Yao S; Wu X
Brain Res; 2022 May; 1782():147814. PubMed ID: 35123924
[TBL] [Abstract][Full Text] [Related]
55. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
Front Immunol; 2021; 12():794770. PubMed ID: 34925379
[TBL] [Abstract][Full Text] [Related]
56. Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide.
Wang K; Lu C; Wang T; Qiao C; Lu L; Wu D; Lu M; Chen R; Fan L; Tang J
Neurochem Int; 2022 Jan; 152():105254. PubMed ID: 34883151
[TBL] [Abstract][Full Text] [Related]
57. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
58. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway.
Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Yao WF; Gao H; Wei MJ
CNS Neurosci Ther; 2019 May; 25(5):575-590. PubMed ID: 30676698
[TBL] [Abstract][Full Text] [Related]
59. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
[TBL] [Abstract][Full Text] [Related]
60. lncRNA HOXA11-AS is involved in fracture healing through regulating mir-124-3p.
Wang XN; Zhang LH; Cui XD; Wang MX; Zhang GY; Yu PL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4771-4776. PubMed ID: 29164588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
